Morganti, Alessio Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 10.248
EU - Europa 8.848
AS - Asia 7.905
SA - Sud America 1.386
AF - Africa 244
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 18
Totale 28.669
Nazione #
US - Stati Uniti d'America 9.932
SG - Singapore 3.748
DE - Germania 3.459
CN - Cina 1.819
SE - Svezia 1.474
BR - Brasile 1.142
FR - Francia 738
IT - Italia 733
VN - Vietnam 726
UA - Ucraina 653
GB - Regno Unito 414
IN - India 376
IE - Irlanda 348
FI - Finlandia 278
ID - Indonesia 242
JP - Giappone 208
CA - Canada 195
PL - Polonia 189
RU - Federazione Russa 151
TR - Turchia 150
HK - Hong Kong 136
BD - Bangladesh 98
AR - Argentina 92
BE - Belgio 77
CI - Costa d'Avorio 68
IQ - Iraq 65
NL - Olanda 64
MX - Messico 62
CZ - Repubblica Ceca 57
ZA - Sudafrica 57
ES - Italia 46
SA - Arabia Saudita 38
AT - Austria 37
EC - Ecuador 37
IR - Iran 34
CO - Colombia 29
MA - Marocco 28
KR - Corea 27
PK - Pakistan 27
UZ - Uzbekistan 27
VE - Venezuela 25
EG - Egitto 24
KE - Kenya 22
PH - Filippine 21
JO - Giordania 19
LT - Lituania 19
CH - Svizzera 18
CL - Cile 18
AE - Emirati Arabi Uniti 16
AU - Australia 15
NP - Nepal 15
JM - Giamaica 14
AZ - Azerbaigian 13
PY - Paraguay 13
RO - Romania 13
EU - Europa 12
MY - Malesia 12
UY - Uruguay 12
IL - Israele 10
TN - Tunisia 10
AL - Albania 9
BG - Bulgaria 9
PE - Perù 9
PT - Portogallo 9
BO - Bolivia 8
KG - Kirghizistan 8
OM - Oman 8
PS - Palestinian Territory 8
RS - Serbia 8
SY - Repubblica araba siriana 8
DZ - Algeria 7
ET - Etiopia 7
KZ - Kazakistan 7
LK - Sri Lanka 7
PA - Panama 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
GR - Grecia 6
HU - Ungheria 6
SN - Senegal 6
AM - Armenia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
LA - Repubblica Popolare Democratica del Laos 5
LU - Lussemburgo 5
NI - Nicaragua 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
BH - Bahrain 4
HR - Croazia 4
NO - Norvegia 4
TH - Thailandia 4
TW - Taiwan 4
CR - Costa Rica 3
EE - Estonia 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
A1 - Anonimo 2
Totale 28.630
Città #
Singapore 2.018
Chandler 1.538
San Jose 977
Ashburn 948
Jacksonville 386
Beijing 381
Dublin 344
San Mateo 310
The Dalles 266
Los Angeles 251
Ho Chi Minh City 238
New York 236
Nanjing 232
Lauterbourg 228
Jakarta 218
Dearborn 216
Ann Arbor 215
Hanoi 195
Wilmington 195
Nürnberg 183
Tokyo 171
Warsaw 168
Boston 167
Munich 166
Milan 159
Woodbridge 154
Frankfurt am Main 140
Hefei 140
Bremen 127
Marseille 119
Hong Kong 115
São Paulo 115
Helsinki 103
Lawrence 103
Izmir 101
Hyderabad 95
Dallas 94
Nanchang 92
Houston 91
Cattolica 89
Moscow 87
Rome 87
Princeton 85
Fairfield 77
Brussels 75
Redwood City 71
Seattle 71
Abidjan 68
Santa Clara 68
Toronto 67
Leawood 61
Buffalo 58
Chicago 53
Council Bluffs 48
London 48
Paris 48
St Louis 47
Shanghai 44
Zhengzhou 44
North York 43
Orem 43
Guangzhou 42
Boardman 41
University Park 39
Kunming 38
Stockholm 38
Shenyang 37
Augusta 36
Düsseldorf 36
Hebei 36
Jiaxing 35
Amsterdam 34
Brooklyn 34
Tianjin 34
Fremont 32
Kent 32
Da Nang 31
Changsha 30
Montreal 30
Nuremberg 30
Turku 30
Lancaster 29
Cambridge 28
Johannesburg 28
Phoenixville 28
Rio de Janeiro 28
Denver 27
Detroit 27
Mountain View 26
Norwalk 26
Pune 26
Lappeenranta 25
Atlanta 24
Belo Horizonte 24
Mumbai 24
Auburn Hills 23
Hangzhou 23
San Francisco 23
Seoul 23
Phoenix 22
Totale 14.556
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 865
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 307
A National project for in vivo dosimetry procedures in radiotherapy: First results 307
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 296
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 231
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 228
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 227
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 226
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 224
A National project for in vivo dosimetry procedures in radiotherapy: First results 220
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 218
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 215
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 210
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 201
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 198
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 191
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 191
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 189
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 188
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 187
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 187
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 187
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 186
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 185
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 182
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 182
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 181
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 179
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 177
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 176
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 174
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 174
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 174
In Vivo Portal Dosimetry by an Ionization Chamber 173
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 173
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 173
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 173
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 170
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 170
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 168
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 167
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 167
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 167
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 166
La formazione iniziale e continua degli insegnanti. Relazioni, comunicazione, metodi. Sessioni parallele 164
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 164
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 164
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 164
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 164
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 164
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 160
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 159
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 158
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 157
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 157
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 157
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 156
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 156
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 155
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 154
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 154
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 153
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 152
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 151
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 151
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 150
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 150
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 150
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 149
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 148
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 148
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 148
Real time transit dosimetry for the breath-hold radiotherapy technique experience 145
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 144
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 142
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 140
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 140
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 139
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 139
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 139
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 139
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 138
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 138
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 137
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 137
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 137
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 136
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 135
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 135
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 134
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 134
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 132
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 130
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 130
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 130
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 130
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 130
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 130
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 129
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 128
Totale 17.484
Categoria #
all - tutte 111.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 0 0 0 0 0 0 0 228 62
2021/20221.822 188 130 32 108 116 69 28 257 73 125 332 364
2022/20234.181 569 590 312 678 273 475 230 342 464 37 160 51
2023/20241.806 66 532 83 149 44 231 103 137 18 49 235 159
2024/20254.019 107 98 253 141 430 95 83 186 658 435 812 721
2025/20269.813 1.551 327 561 957 1.835 562 1.787 633 800 767 33 0
Totale 29.472